Yabao Pharmaceutical Group Co Ltd (600351) — Cash Flow Reinvestment Rate
Yabao Pharmaceutical Group Co Ltd (600351) has a Cash Flow Reinvestment Rate of 0.06x as of September 2025, reinvesting CN¥7.58 Million (capex CN¥7.58 Million ) from operating cash flow of CN¥129.49 Million. See 600351 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yabao Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2001–2024)
Historical reinvestment intensity for Yabao Pharmaceutical Group Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see Yabao Pharmaceutical Group Co Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Yabao Pharmaceutical Group Co Ltd (2001–2024)
Year-by-year capital reinvestment analysis for Yabao Pharmaceutical Group Co Ltd. See Yabao Pharmaceutical Group Co Ltd (600351) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.07x | CN¥34.77 Million | CN¥471.69 Million | CN¥34.66 Million | ▼ -83.9% |
| 2023 | 0.46x | CN¥227.23 Million | CN¥497.55 Million | CN¥99.86 Million | ▲ +32.3% |
| 2022 | 0.35x | CN¥158.96 Million | CN¥460.46 Million | CN¥62.23 Million | ▲ +14.4% |
| 2021 | 0.30x | CN¥132.04 Million | CN¥437.50 Million | CN¥95.05 Million | ▼ -45.6% |
| 2020 | 0.55x | CN¥211.38 Million | CN¥380.96 Million | CN¥62.87 Million | ▲ +25.6% |
| 2019 | 0.44x | CN¥187.75 Million | CN¥425.17 Million | CN¥157.09 Million | ▲ +124.1% |
| 2018 | 0.20x | CN¥84.06 Million | CN¥426.60 Million | CN¥68.01 Million | ▼ -74.1% |
| 2017 | 0.76x | CN¥122.98 Million | CN¥161.73 Million | CN¥99.34 Million | ▲ +21.5% |
| 2016 | 0.63x | CN¥97.61 Million | CN¥155.95 Million | CN¥84.46 Million | ▼ -24.0% |
| 2015 | 0.82x | CN¥118.14 Million | CN¥143.47 Million | CN¥101.68 Million | ▼ -15.4% |
| 2014 | 0.97x | CN¥173.84 Million | CN¥178.63 Million | CN¥173.84 Million | ▼ -44.2% |
| 2013 | 1.74x | CN¥99.02 Million | CN¥56.80 Million | CN¥99.02 Million | ▼ -40.6% |
| 2011 | 2.94x | CN¥119.56 Million | CN¥40.73 Million | CN¥119.56 Million | ▼ -70.9% |
| 2010 | 10.09x | CN¥187.30 Million | CN¥18.57 Million | CN¥187.30 Million | ▲ +1278.1% |
| 2009 | 0.73x | CN¥269.82 Million | CN¥368.56 Million | CN¥269.82 Million | ▼ -48.9% |
| 2008 | 1.43x | CN¥147.56 Million | CN¥102.90 Million | CN¥147.56 Million | ▲ +384.1% |
| 2007 | 0.30x | CN¥31.31 Million | CN¥105.69 Million | CN¥31.31 Million | ▼ -92.1% |
| 2006 | 3.77x | CN¥43.70 Million | CN¥11.59 Million | CN¥43.70 Million | ▼ -8.7% |
| 2005 | 4.13x | CN¥108.95 Million | CN¥26.40 Million | CN¥108.95 Million | ▲ +62.3% |
| 2004 | 2.54x | CN¥202.81 Million | CN¥79.73 Million | CN¥202.81 Million | ▲ +125.7% |
| 2002 | 1.13x | CN¥27.38 Million | CN¥24.29 Million | CN¥27.38 Million | ▲ +15.4% |
| 2001 | 0.98x | CN¥23.04 Million | CN¥23.59 Million | CN¥23.04 Million | — |